COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
FRA:CBHD - Deutsche Boerse Ag - DK0060448595 - Common Stock - Currency: EUR
Overall CBHD gets a fundamental rating of 6 out of 10. We evaluated CBHD against 58 industry peers in the Health Care Equipment & Supplies industry. While CBHD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CBHD has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year CBHD was profitable.
In the past year CBHD had a positive cash flow from operations.
In the past 5 years CBHD has always been profitable.
Each year in the past 5 years CBHD had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CBHD (9.45%) is better than 86.21% of its industry peers.
CBHD has a Return On Equity of 25.33%. This is amongst the best in the industry. CBHD outperforms 93.10% of its industry peers.
CBHD's Return On Invested Capital of 15.63% is amongst the best of the industry. CBHD outperforms 96.55% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CBHD is significantly above the industry average of 8.02%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.45% | ||
| ROE | 25.33% | ||
| ROIC | 15.63% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
1.3 Margins
With an excellent Profit Margin value of 16.35%, CBHD belongs to the best of the industry, outperforming 87.93% of the companies in the same industry.
In the last couple of years the Profit Margin of CBHD has declined.
CBHD has a Operating Margin of 26.90%. This is amongst the best in the industry. CBHD outperforms 93.10% of its industry peers.
In the last couple of years the Operating Margin of CBHD has declined.
The Gross Margin of CBHD (67.52%) is better than 74.14% of its industry peers.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.9% | ||
| PM (TTM) | 16.35% | ||
| GM | 67.52% |
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
CBHD has more shares outstanding than it did 1 year ago.
CBHD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CBHD has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.17 indicates that CBHD is not in any danger for bankruptcy at the moment.
CBHD has a better Altman-Z score (4.17) than 75.86% of its industry peers.
CBHD has a debt to FCF ratio of 4.64. This is a neutral value as CBHD would need 4.64 years to pay back of all of its debts.
CBHD has a Debt to FCF ratio of 4.64. This is in the better half of the industry: CBHD outperforms 62.07% of its industry peers.
A Debt/Equity ratio of 0.96 indicates that CBHD is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.96, CBHD is doing worse than 79.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 4.64 | ||
| Altman-Z | 4.17 |
ROIC/WACC2.59
WACC6.03%
2.3 Liquidity
CBHD has a Current Ratio of 1.02. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.02, CBHD is not doing good in the industry: 74.14% of the companies in the same industry are doing better.
CBHD has a Quick Ratio of 1.02. This is a bad value and indicates that CBHD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.66, CBHD is not doing good in the industry: 74.14% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased by -7.50% in the last year.
The Earnings Per Share has been growing slightly by 2.72% on average over the past years.
CBHD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.89%.
The Revenue has been growing by 8.54% on average over the past years. This is quite good.
EPS 1Y (TTM)-7.5%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-22.08%
Revenue 1Y (TTM)8.89%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%5.22%
3.2 Future
The Earnings Per Share is expected to grow by 11.14% on average over the next years. This is quite good.
Based on estimates for the next years, CBHD will show a small growth in Revenue. The Revenue will grow by 7.24% on average per year.
EPS Next Y14.67%
EPS Next 2Y13.5%
EPS Next 3Y13.5%
EPS Next 5Y11.14%
Revenue Next Year5.69%
Revenue Next 2Y6.84%
Revenue Next 3Y7.29%
Revenue Next 5Y7.24%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 28.94, the valuation of CBHD can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CBHD indicates a somewhat cheap valuation: CBHD is cheaper than 72.41% of the companies listed in the same industry.
CBHD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.45.
Based on the Price/Forward Earnings ratio of 20.74, the valuation of CBHD can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CBHD is valued a bit cheaper than 67.24% of the companies in the same industry.
CBHD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.94 | ||
| Fwd PE | 20.74 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CBHD is valued a bit cheaper than the industry average as 62.07% of the companies are valued more expensively.
CBHD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 77.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.89 | ||
| EV/EBITDA | 16.79 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CBHD may justify a higher PE ratio.
A more expensive valuation may be justified as CBHD's earnings are expected to grow with 13.50% in the coming years.
PEG (NY)1.97
PEG (5Y)10.64
EPS Next 2Y13.5%
EPS Next 3Y13.5%
5. Dividend
5.1 Amount
CBHD has a Yearly Dividend Yield of 3.65%. Purely for dividend investing, there may be better candidates out there.
CBHD's Dividend Yield is rather good when compared to the industry average which is at 2.07. CBHD pays more dividend than 98.28% of the companies in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.65% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.57%.
Dividend Growth(5Y)5.57%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
109.07% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP109.07%
EPS Next 2Y13.5%
EPS Next 3Y13.5%
FRA:CBHD (7/3/2025, 7:00:00 PM)
80.44
+0.08 (+0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners27.78%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.91B
Analysts67.41
Price Target101.04 (25.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.65% |
Yearly Dividend2.81
Dividend Growth(5Y)5.57%
DP109.07%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.35%
Min EPS beat(2)-15.38%
Max EPS beat(2)-15.32%
EPS beat(4)0
Avg EPS beat(4)-9.27%
Min EPS beat(4)-15.38%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-7.43%
EPS beat(12)1
Avg EPS beat(12)-6.85%
EPS beat(16)2
Avg EPS beat(16)-6.39%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)-0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-1.56%
Max Revenue beat(4)0.01%
Revenue beat(8)1
Avg Revenue beat(8)-1.53%
Revenue beat(12)2
Avg Revenue beat(12)-1.09%
Revenue beat(16)4
Avg Revenue beat(16)-0.74%
PT rev (1m)-13.04%
PT rev (3m)-19.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.36%
EPS NY rev (1m)0%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.94 | ||
| Fwd PE | 20.74 | ||
| P/S | 4.54 | ||
| P/FCF | 25.89 | ||
| P/OCF | 20.07 | ||
| P/B | 7.03 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.79 |
EPS(TTM)2.78
EY3.46%
EPS(NY)3.88
Fwd EY4.82%
FCF(TTM)3.11
FCFY3.86%
OCF(TTM)4.01
OCFY4.98%
SpS17.72
BVpS11.44
TBVpS-7.9
PEG (NY)1.97
PEG (5Y)10.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.45% | ||
| ROE | 25.33% | ||
| ROCE | 19.74% | ||
| ROIC | 15.63% | ||
| ROICexc | 15.97% | ||
| ROICexgc | 87.72% | ||
| OM | 26.9% | ||
| PM (TTM) | 16.35% | ||
| GM | 67.52% | ||
| FCFM | 17.53% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
ROICexc(3y)17.22%
ROICexc(5y)29.72%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.23%
ROCE(5y)39.82%
ROICexcg growth 3Y7.74%
ROICexcg growth 5Y2.01%
ROICexc growth 3Y-30.17%
ROICexc growth 5Y-21.96%
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 4.64 | ||
| Debt/EBITDA | 1.96 | ||
| Cap/Depr | 105.92% | ||
| Cap/Sales | 5.09% | ||
| Interest Coverage | 8.47 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 107.24% | ||
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | 4.17 |
F-Score6
WACC6.03%
ROIC/WACC2.59
Cap/Depr(3y)114.16%
Cap/Depr(5y)140.02%
Cap/Sales(3y)5.02%
Cap/Sales(5y)6.04%
Profit Quality(3y)58.21%
Profit Quality(5y)66.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.5%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-22.08%
EPS Next Y14.67%
EPS Next 2Y13.5%
EPS Next 3Y13.5%
EPS Next 5Y11.14%
Revenue 1Y (TTM)8.89%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%5.22%
Revenue Next Year5.69%
Revenue Next 2Y6.84%
Revenue Next 3Y7.29%
Revenue Next 5Y7.24%
EBIT growth 1Y6.6%
EBIT growth 3Y4.66%
EBIT growth 5Y5.57%
EBIT Next Year23.01%
EBIT Next 3Y14.31%
EBIT Next 5Y12.49%
FCF growth 1Y33.03%
FCF growth 3Y-24.77%
FCF growth 5Y-17.33%
OCF growth 1Y28.46%
OCF growth 3Y-19.49%
OCF growth 5Y-8.71%